Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
593PDF: 1753Supplementary: 222Appendix: 161 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1833PDF: 486SUPPLEMENTARY MATERIAL: 291GRAPHICAL ABSTRACT: 258HTML: 4 -
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3236PDF: 466Appendix: 361HTML: 20 -
Lipoprotein(a): what clinicians need to know
151PDF: 278HTML: 18 -
-
-
Applicability of obesity clinical practice guidelines in low- and middle-income countries
900PDF: 473Appendix: 131HTML: 4 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
9986PDF: 6332Appendix: 1006 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
703PDF: 162Supplementary: 140Appendix: 103HTML: 8 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
699PDF: 167Supplementary: 133Appendix: 105HTML: 7 -
Epidemiology of peripartum cardiomyopathy in Africa
2131PDF: 470HTML: 44 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
73PDF: 124Supplementary: 82HTML: 11 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1020pdf: 210Supplementary Material: 35HTML: 83 -
Evolving targets for heart failure: the journey so far
1922pdf: 275HTML: 4 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2264PDF: 622Conflict of interest: 310SUPPLEMENTARY MATERIAL: 248HTML: 28

